Global Neurological Disorder Diagnostics Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI12244133

Publication Date:

December 19, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Neurological Disorder Diagnostics market size was valued at US$ 9859.1 million in 2023. With growing demand in downstream market, the Neurological Disorder Diagnostics is forecast to a readjusted size of US$ 13200 million by 2030 with a CAGR of 4.3% during review period.
The research report highlights the growth potential of the global Neurological Disorder Diagnostics market. Neurological Disorder Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neurological Disorder Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neurological Disorder Diagnostics market.
Neurological disorders diagnostic tools are tools used to diagnose various neurological disorders.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Neurological Disorder Diagnostics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neurological Disorder Diagnostics market. It may include historical data, market segmentation by Type (e.g., Imaging Techniques, In Vitro Diagnostics Techniques), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neurological Disorder Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neurological Disorder Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neurological Disorder Diagnostics industry. This include advancements in Neurological Disorder Diagnostics technology, Neurological Disorder Diagnostics new entrants, Neurological Disorder Diagnostics new investment, and other innovations that are shaping the future of Neurological Disorder Diagnostics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neurological Disorder Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for Neurological Disorder Diagnostics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neurological Disorder Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neurological Disorder Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neurological Disorder Diagnostics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neurological Disorder Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neurological Disorder Diagnostics market.
Market Segmentation:
Neurological Disorder Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Imaging Techniques
In Vitro Diagnostics Techniques
Segmentation by application
Hospitals and Clinics
Diagnostic Centers
Ambulatory Care Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Siemens
Philips
GE
Esaote
Masimo
Croton Healthcare
Neusoft

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neurological Disorder Diagnostics Market Size 2019-2030
2.1.2 Neurological Disorder Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neurological Disorder Diagnostics Segment by Type
2.2.1 Imaging Techniques
2.2.2 In Vitro Diagnostics Techniques
2.3 Neurological Disorder Diagnostics Market Size by Type
2.3.1 Neurological Disorder Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neurological Disorder Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Neurological Disorder Diagnostics Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Diagnostic Centers
2.4.3 Ambulatory Care Centers
2.5 Neurological Disorder Diagnostics Market Size by Application
2.5.1 Neurological Disorder Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neurological Disorder Diagnostics Market Size Market Share by Application (2019-2024)
3 Neurological Disorder Diagnostics Market Size by Player
3.1 Neurological Disorder Diagnostics Market Size Market Share by Players
3.1.1 Global Neurological Disorder Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Neurological Disorder Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Neurological Disorder Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Neurological Disorder Diagnostics by Regions
4.1 Neurological Disorder Diagnostics Market Size by Regions (2019-2024)
4.2 Americas Neurological Disorder Diagnostics Market Size Growth (2019-2024)
4.3 APAC Neurological Disorder Diagnostics Market Size Growth (2019-2024)
4.4 Europe Neurological Disorder Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa Neurological Disorder Diagnostics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Neurological Disorder Diagnostics Market Size by Country (2019-2024)
5.2 Americas Neurological Disorder Diagnostics Market Size by Type (2019-2024)
5.3 Americas Neurological Disorder Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurological Disorder Diagnostics Market Size by Region (2019-2024)
6.2 APAC Neurological Disorder Diagnostics Market Size by Type (2019-2024)
6.3 APAC Neurological Disorder Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Neurological Disorder Diagnostics by Country (2019-2024)
7.2 Europe Neurological Disorder Diagnostics Market Size by Type (2019-2024)
7.3 Europe Neurological Disorder Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neurological Disorder Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Neurological Disorder Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Neurological Disorder Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Neurological Disorder Diagnostics Market Forecast
10.1 Global Neurological Disorder Diagnostics Forecast by Regions (2025-2030)
10.1.1 Global Neurological Disorder Diagnostics Forecast by Regions (2025-2030)
10.1.2 Americas Neurological Disorder Diagnostics Forecast
10.1.3 APAC Neurological Disorder Diagnostics Forecast
10.1.4 Europe Neurological Disorder Diagnostics Forecast
10.1.5 Middle East & Africa Neurological Disorder Diagnostics Forecast
10.2 Americas Neurological Disorder Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Neurological Disorder Diagnostics Market Forecast
10.2.2 Canada Neurological Disorder Diagnostics Market Forecast
10.2.3 Mexico Neurological Disorder Diagnostics Market Forecast
10.2.4 Brazil Neurological Disorder Diagnostics Market Forecast
10.3 APAC Neurological Disorder Diagnostics Forecast by Region (2025-2030)
10.3.1 China Neurological Disorder Diagnostics Market Forecast
10.3.2 Japan Neurological Disorder Diagnostics Market Forecast
10.3.3 Korea Neurological Disorder Diagnostics Market Forecast
10.3.4 Southeast Asia Neurological Disorder Diagnostics Market Forecast
10.3.5 India Neurological Disorder Diagnostics Market Forecast
10.3.6 Australia Neurological Disorder Diagnostics Market Forecast
10.4 Europe Neurological Disorder Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Neurological Disorder Diagnostics Market Forecast
10.4.2 France Neurological Disorder Diagnostics Market Forecast
10.4.3 UK Neurological Disorder Diagnostics Market Forecast
10.4.4 Italy Neurological Disorder Diagnostics Market Forecast
10.4.5 Russia Neurological Disorder Diagnostics Market Forecast
10.5 Middle East & Africa Neurological Disorder Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Neurological Disorder Diagnostics Market Forecast
10.5.2 South Africa Neurological Disorder Diagnostics Market Forecast
10.5.3 Israel Neurological Disorder Diagnostics Market Forecast
10.5.4 Turkey Neurological Disorder Diagnostics Market Forecast
10.5.5 GCC Countries Neurological Disorder Diagnostics Market Forecast
10.6 Global Neurological Disorder Diagnostics Forecast by Type (2025-2030)
10.7 Global Neurological Disorder Diagnostics Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Siemens
11.1.1 Siemens Company Information
11.1.2 Siemens Neurological Disorder Diagnostics Product Offered
11.1.3 Siemens Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Siemens Main Business Overview
11.1.5 Siemens Latest Developments
11.2 Philips
11.2.1 Philips Company Information
11.2.2 Philips Neurological Disorder Diagnostics Product Offered
11.2.3 Philips Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Philips Main Business Overview
11.2.5 Philips Latest Developments
11.3 GE
11.3.1 GE Company Information
11.3.2 GE Neurological Disorder Diagnostics Product Offered
11.3.3 GE Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GE Main Business Overview
11.3.5 GE Latest Developments
11.4 Esaote
11.4.1 Esaote Company Information
11.4.2 Esaote Neurological Disorder Diagnostics Product Offered
11.4.3 Esaote Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Esaote Main Business Overview
11.4.5 Esaote Latest Developments
11.5 Masimo
11.5.1 Masimo Company Information
11.5.2 Masimo Neurological Disorder Diagnostics Product Offered
11.5.3 Masimo Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Masimo Main Business Overview
11.5.5 Masimo Latest Developments
11.6 Croton Healthcare
11.6.1 Croton Healthcare Company Information
11.6.2 Croton Healthcare Neurological Disorder Diagnostics Product Offered
11.6.3 Croton Healthcare Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Croton Healthcare Main Business Overview
11.6.5 Croton Healthcare Latest Developments
11.7 Neusoft
11.7.1 Neusoft Company Information
11.7.2 Neusoft Neurological Disorder Diagnostics Product Offered
11.7.3 Neusoft Neurological Disorder Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Neusoft Main Business Overview
11.7.5 Neusoft Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂